ArticleCureus2025
Knowledge, Attitudes, and Practices of Dermatologists on Chronic Pruritus and Its Management.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Chronic pruritus (CP) is a prevalent and distressing condition with a significant impact on patients' quality of life. Despite advances in understanding its pathophysiology, management remains challenging, necessitating insights into dermatologists' perspectives on CP treatment. Objective This study aimed to assess the knowledge, attitudes, and practices (KAP) of dermatologists regarding CP management, with a focus on antihistamine use. Methods A cross-sectional study was conducted among dermatologists across India. A total of 220 participants completed the quantitative KAP questionnaire, while 15 (6.82%) underwent qualitative interviews. Data were analyzed using descriptive statistics and thematic analysis. Results Dermatologists showed good knowledge of CP pathophysiology, with histamine and H1 receptors recognized as key mediators. Antihistamines were widely used, and many respondents reported a shift toward once-daily regimens to improve symptom control and adherence. Patient education was identified as a critical need, alongside further safety and efficacy data in high-risk groups. Conclusion Dermatologists emphasized a patient-centered approach, prioritizing the identification of underlying causes while addressing symptoms. Hydroxyzine and its sustained-release formulation were regarded as convenient and effective, supporting simplified dosing and better adherence. Strengthening patient education remains essential to optimizing CP management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.